What are the guidelines on the follow-up and surveillance of patients with basal cell carcinoma (BCC)?

Updated: Mar 02, 2020
  • Author: Robert S Bader, MD; Chief Editor: William D James, MD  more...
  • Print
Answer

The NCCN recommends the following measures [7] :

  • Complete skin examination every 6-12 months for life
  • Sun protection
  • Self-examination

AAD recommendations for the follow-up of BCC and reduction of risk for future skin cancer are as follows [107] :

  • After diagnosis of a first BCC, skin cancer screening for new keratinocyte cancers (BCC or cutaneous squamous cell carcinoma) and for melanoma should be performed on at least an annual basis.
  • Patients with a history of BCC should be counseled on skin self-examination and sun protection.
  • The use of topical and oral retinoids (eg, tretinoin, retinol, acitretin, isotretinoin) is not recommended to reduce the incidence of future keratinocyte cancers in those with a history of BCC.
  • Dietary supplementation of selenium and β-carotene is not recommended to reduce the incidence of future keratinocyte cancers in those with a history of BCC.
  • There is insufficient evidence to make a recommendation on the use of oral nicotinamide, α-difluoromethylornithine (DFMO), or celecoxib in the chemoprevention of BCC.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!